You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Failed hypomethylating therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

Recruiting
  • Refractory Chronic Myelomonocytic Leukemia
  • Refractory Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2021

MDS, Progressive Disease Trial in Buffalo, Winston-Salem (CPI-613, Hydroxychloroquine)

Withdrawn
  • Myelodysplastic Syndromes
  • Progressive Disease
  • Buffalo, New York
  • +1 more
Apr 8, 2021

Myelodysplastic Syndrome Trial in Seoul (CG200745 PPA)

Recruiting
  • Myelodysplastic Syndrome
  • CG200745 PPA
  • Seoul, Korea, Republic of
    Asan Medical Center, Samsung Medical Center, Seoul National Univ
Jan 4, 2022

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
  • Cadonilimab Injection
  • Ramucirumab Injection
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 14, 2023

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting
  • Advanced Solid Tumors With Neuroendocrine Differentiation
  • (no location specified)
Nov 27, 2023

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • chidamide combined with fulvestrant
  • (no location specified)
Mar 28, 2023

Solid Tumor Trial in Seoul (EU103)

Not yet recruiting
  • Solid Tumor
  • Seoul, Korea, Republic of
    Samsung Seoul Hospital
Apr 3, 2023

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy Trial in Tianjin (Cadonilimab Injection,

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Dec 7, 2022

Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • EU307 CAR-T Cell
  • (no location specified)
Mar 13, 2023

Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

Recruiting
  • Colorectal Cancer
  • HAIC
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 24, 2023

Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
May 26, 2023

Advanced Cancer Trial in Seoul (IMC-002)

Recruiting
  • Advanced Cancer
  • IMC-002
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 2, 2022

LMV-12 Combined With Osimertinib in NSCLC

Not yet recruiting
  • Non Small Cell Lung Cancer
  • LMV-12(HE003) and Osimertinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 25, 2023

Cervical Cancer Trial in China (Disitamab Vedotin, Zimberelimab)

Not yet recruiting
  • Cervical Cancer
  • Bengbu, Anhui, China
  • +11 more
Nov 23, 2023

Metastatic Breast Cancer in the Liver Trial in Shanghai (Cryoablation Combined with Tirelizumab and Bevacizumab)

Recruiting
  • Metastatic Breast Cancer in the Liver
  • Cryoablation Combined with Tirelizumab and Bevacizumab
  • Shanghai, Shanghai, China
  • +1 more
Jun 6, 2022

Gastric Cancer Trial in Seoul (Apatinib mesylate)

Completed
  • Gastric Cancer
  • Apatinib mesylate
  • Seoul, Songpa-gu, Korea, Republic of
    Asan medical center
Jul 20, 2022

Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Autologous Adoptive immune cells
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Pudong Medical Center
Jun 24, 2022

Gastrointestinal Cancer Trial in Tianjin (Pemigatinib)

Recruiting
  • Gastrointestinal Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Dec 7, 2022

Salvage Surgeries for Splanchnic Artery Aneurysms After Failed

Completed
  • Failure in Endovascular Therapy
  • +3 more
  • Aneurysmectomy
  • Taichung, Taiwan
    China Medical University Hospital, Department of Surgery
Feb 13, 2023